정형외과 내비게이션 시스템 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the orthopedic navigation systems market size in 2026 is estimated at USD 3.55 billion, growing from 2025 value of USD 3.14 billion with 2031 projections showing USD 6.55 billion, growing at 13.06% CAGR over 2026-2031.

This report is Segmented by Technology (Electromagnetic Localizers, Optical Tracking, and More), by Application (Knee Surgery, Spine Surgery, and More), by End User (Hospitals, Ambulatory Surgical Centers, and More), and by Geography (North America, Europe, Asia-Pacific, and More). The Market Sizes and Forecasts are Provided in Terms of Value (USD).

Global Orthopedic Navigation Systems Market Trends and Insights

Rising Adoption of Minimally Invasive Orthopedic Procedures

Surgeons increasingly favor smaller incisions that minimize tissue trauma yet still demand sub-millimeter implant accuracy. Navigation assists by guiding instruments in three-dimensional space, enabling 93% alignment within +-2° during total knee arthroplasty.Economic benefits accrue when shorter inpatient stays and quicker rehabilitation reduce payer spend. Fluoroscopy-integrated systems further cut radiation exposure by 91.8% compared with conventional methods.

Expanding Installed Base of Robotic-Assisted Surgery Platforms

Hospitals that already rely on robotics are layering navigation software on existing arms to form comprehensive ecosystems. Stryker's forthcoming Mako 4 release extends its footprint from hips and knees to spine and shoulders, embedding the Q Guidance module for seamless imaging-robot synchronization. Peer-reviewed research shows robotic navigation flattens the learning curve in hip arthroplasty for early-career surgeons, achieving veteran-level accuracy sooner.

High Capital & Per-Procedure Costs of Navigation Platforms

Systems list from USD 475,000 to more than USD 1 million, while disposables can add USD 442-1,500 each case. Reimbursement gaps often push facilities to self-fund upgrades. Some evidence shows neutrality is achieved when navigation averts 17 spine revisions per center. Lower-cost handheld models are gradually easing the financial barrier for mid-size hospitals and ASCs.

Other drivers and restraints analyzed in the detailed report include:

1. Advances in Real-Time Imaging & Sensor Fusion for Intra-Op Guidance
2. Growing Burden of Musculoskeletal Disorders in Ageing Populations
3. Steep Learning Curve & Workflow Disruption for Surgical Teams

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Optical systems controlled 42.02% of the orthopedic navigation systems market in 2025, thanks to well-validated camera arrays that deliver sub-millimeter accuracy during high-volume knee replacements. Augmented- and mixed-reality solutions now post the segment's fastest 17.85% CAGR, propelled by head-mounted displays that place holographic guides inside the surgeon's field of view and remove line-of-sight constraints common to fixed cameras. Electromagnetic trackers are gaining ground for spine work where metallic instruments obscure optical markers, whereas fluoroscopy-based guidance remains a staple in trauma rooms needing instant imaging. MRI-specific platforms hold a niche for soft-tissue-driven tumor resections that depend on detailed contrast.

Competition is intensifying as incumbents meld sensors, GPUs, and cloud analytics into single packages. Smith+Nephew's TESSA Spatial Surgery System runs in real-time on NVIDIA chips to guide ACL reconstruction without external cameras, illustrating the shift toward compact hybrid devices. Proprietary AI modules now auto-segment bone on intra-op scans and fine-tune instrument paths, trimming manual steps. With optical reliability already proven, companies seek differentiation by shrinking footprints, cutting cables, and integrating AR. As price points drop, the orthopedic navigation systems market will likely see technology overlap rather than a single-modality winner.

Complete Report Scope:

• By Technology
  • Electromagnetic Localizers
  • Optical Tracking
  • Fluoroscopy-based
  • MRI-based
  • Augmented / Mixed Reality Systems
  • Other Emerging Technologies
• By Application
  • Knee Surgery
  • Spine Surgery
  • Hip Surgery
  • Shoulder & Upper-Extremity
  • Trauma & Sports Injury
  • Other Applications
• By End User
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 40.74% of sales in 2025, reflecting early adoption, clear CPT codes that reimburse navigation in complex joints, and the presence of vendors able to provide 24/7 field support. Migration of hip and knee replacements to ASCs intensifies demand for compact platforms that replicate hospital-level precision. A 26% cost reduction versus hospital outpatient departments has been documented when ASCs deploy navigated protocols for joint work. Canada mirrors this path with provincial funding programs that incentivize data-verified outcomes, while Mexico gains from cross-border device trade and private hospital growth.

Europe forms the next largest block, with Germany, the United Kingdom, and France adopting stringent evidence-based guidelines favoring navigation when alignment accuracy predicts longevity of high-priced implants. Diverse reimbursement regimes mean uptake varies, statutory payers in Germany cover navigation disposables, whereas southern markets rely on private insurers or self-pay models. Academic hubs such as Charite in Berlin and Oxford University Hospitals publish robust registries that validate technology, influencing continental standards. Emerging Central-Eastern nations now modernize orthopedic departments with EU recovery funds and see navigation as a path to curb expensive revisions.

Asia Pacific is the fastest-growing region, posting a 9.24% CAGR to 2031 as demographic aging meets rising income levels. India's arthroplasty implant sector is expanding near 25% CAGR, yet limited awareness of joint-replacement options caps immediate volumes. China's penetration remains low, with only 8.31% of hip surgeons using navigation or robotics, but state 5-year plans targeting advanced healthcare are expected to lift utilization. Japan and South Korea already operate mature reimbursement schemes, while Australia's national joint registry proves the link between navigation and lower revision risk, reinforcing adoption. Southeast Asian markets draw medical tourists seeking high-tech surgery, nudging private hospitals to invest in navigation as a competitive differentiator.

1. Stryker
2. Zimmer Biomet
3. Smiths Group
4. Medtronic
5. Brain Lab
6. NuVasive
7. B. Braun
8. Arthrex
9. Siemens Healthineers
10. MicroPort MedTech
11. Exactech
12. OrthAlign
13. 7D Surgical
14. Intellijoint Surgical
15. Corin Group
16. DePuy Synthes
17. Joimax
18. Globus Medical
19. Karl Storz
20. Scopis (Stryker)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Adoption of Minimally Invasive Orthopedic Procedures
  • 4.2.2 Expanding Installed Base of Robotic-Assisted Surgery Platforms
  • 4.2.3 Advances In Real-Time Imaging & Sensor Fusion for Intra-Op Guidance
  • 4.2.4 Growing Burden of Musculoskeletal Disorders in Ageing Populations
  • 4.2.5 Hand-Held & Pin-Less Low-Cost Devices Targeting ASC Settings
  • 4.2.6 FDA Real-World Evidence (RWE) Programs Accelerating Post-Market Data Use
• 4.3 Market Restraints
  • 4.3.1 High Capital & Per-Procedure Costs of Navigation Platforms
  • 4.3.2 Steep Learning Curve & Workflow Disruption for Surgical Teams
  • 4.3.3 Stringent Multi-Region Regulatory Approval & Device-Recall Risk
  • 4.3.4 Competitive Cannibalization by Fully Integrated Orthopedic Robots
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value)

• 5.1 By Technology
  • 5.1.1 Electromagnetic Localizers
  • 5.1.2 Optical Tracking
  • 5.1.3 Fluoroscopy-based
  • 5.1.4 MRI-based
  • 5.1.5 Augmented / Mixed Reality Systems
  • 5.1.6 Other Emerging Technologies
• 5.2 By Application
  • 5.2.1 Knee Surgery
  • 5.2.2 Spine Surgery
  • 5.2.3 Hip Surgery
  • 5.2.4 Shoulder & Upper-Extremity
  • 5.2.5 Trauma & Sports Injury
  • 5.2.6 Other Applications
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers (ASCs)
  • 5.3.3 Others
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Stryker
  • 6.3.2 Zimmer Biomet
  • 6.3.3 Smith & Nephew
  • 6.3.4 Medtronic plc
  • 6.3.5 Brainlab
  • 6.3.6 NuVasive
  • 6.3.7 B. Braun SE
  • 6.3.8 Arthrex
  • 6.3.9 Siemens Healthineers
  • 6.3.10 MicroPort MedTech
  • 6.3.11 Exactech
  • 6.3.12 OrthAlign
  • 6.3.13 7D Surgical
  • 6.3.14 Intellijoint Surgical
  • 6.3.15 Corin Group
  • 6.3.16 DePuy Synthes
  • 6.3.17 Joimax
  • 6.3.18 Globus Medical
  • 6.3.19 Karl Storz
  • 6.3.20 Scopis (Stryker)

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment